[Strongyloides stercoralis hyperinfection syndrome in a Colombian patient receiving immunosuppressive treatment].
Rojo-Marcos
Gerardo
G
Cuadros-González
Juan
J
González-Juárez
María Jesús
MJ
Gómez-Ayerbe
Cristina
C
D000208:Acute Disease; D000328:Adult; D000818:Animals; D003105:Colombia / Q000208:ethnology; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D019353:Endemic Diseases; D017809:Fatal Outcome; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008174:Lung Diseases, Parasitic / Q000209:etiology* / Q000469:parasitology; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D008297:Male; D011241:Prednisone / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D012131:Respiratory Insufficiency / Q000209:etiology; D012772:Shock, Septic / Q000209:etiology; D017171:Strongyloides stercoralis / Q000302:isolation & purification*; D013322:Strongyloidiasis / Q000453:epidemiology / Q000209:etiology* / Q000469:parasitology
D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D011241:Prednisone